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g.2013.1Abstract Background: The history of natural products used in ancient times and in folk medicine
these days, around the world, is the basis for the use of many therapeutic drugs in modern day med-
icine. Andrographia paniculata belongs to the family Acanthaceae or Kalmegh and is commonly
known as ‘king of bitters’. It is extensively used as home remedy for various diseases in Indian
traditional system as well as in tribal system in India for multiple clinical applications.
Aim: In our present work, extracts of these ayurvedic plants were tested for their anticlastogenic,
antimutagenic and anticarcinogenic properties against Aﬂatoxin B1 induced toxicity.
Materials and methods: We used the in vitro method i.e. human lymphocytes culture and in vivo
method in bone marrow cells of albino mice, while the parameters studied included chromosomal
aberrations (CA), sister chromatid exchanges (SCEs) and cell growth kinetics (RI) both in the
presence as well as in the absence of exogenous metabolic activation system for in vitro studies,
whereas total aberrant cells and the frequencies of aberrations were used for in vivo methods.ations; SCE, sister chromatid
Aﬂatoxin B1; AE, extracts of
9335753122.
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164 M.S. Ahmad et al.Results: A. paniculata extracts signiﬁcantly reduced chromosomal aberrations from 35.0%,
62.0% and 69.0% level [at 24, 48, and 72 h due to Aﬂatoxin B1] to 21.72%, 44.0% and 52.0%,
similarly sister chromatid exchanges were reduced from 14.60 per cell to 7.50 per cell at 48 h of
treatments and replication index was enhanced in vitro for each concentration and duration of
treatment.
Conclusion: In conclusion A. paniculata extracts signiﬁcantly reduced the number of aberrant
cells and frequencies of aberration per cell at each concentration and duration of exposure
in vivo; similarly it reduced chromosomal aberrations and sister chromatid exchanges and replica-
tion index was enhanced in vitro that was statistically signiﬁcant at <0.05 level.
 2014 Production and hosting by Elsevier B.V. on behalf of Ain Shams University.1. Introduction
The history of natural product used in ancient times and in
folk medicine around the world, is the basis for the use of
many therapeutic drugs in modern day medicine. Tradition-
ally, natural plant products have been the source in the search
for new drugs by pharmaceutical companies [1]. Earlier we
have worked on certain bioactivators like vitamins, carote-
noids, ﬂavonoids, ellagic acid and extracts of Caesalpinia
bonducella, Agaricus bisporus, Terminalia arjuna and their anti-
mutagenic and anticarcinogenic potentials were noticed, using
in vitro and in vivo methods [2–6].
Andrographia paniculata belongs to the family Acanthaceae
or Kalmegh and is commonly known as ‘king of bitters’. It is
widely distributed throughout tropical Asian countries often in
isolated patches. Native populations of plants are spread
throughout the south India and Sri Lanka which perhaps
represent the center of origin and diversity of the species. It
is extensively used in Ayurveda, Unani and Siddha medicines
as home remedy for various diseases in India. The therapeutic
value of kalmegh is due to its mechanism of action by enzyme
induction. It is used to treat gastro intestinal tract, upper respi-
ratory infections, fever, herpes, sore throat, hepatitis and a
variety of other chronic and infectious diseases [7]. Therapeu-
tically important active principal of kalmegh found in aerial
part is Andrographolide (C20H30O5, mp 230–239 C). It is
colorless, crystalline bitter in taste and known as diterpene
lactone [8].
Sheeja et al. [9] reported that administration of methanolic
extract of kalmegh produced complete inhibition of carra-
geenan induced inﬂammation compared with the control.
Verma and Vinayak [10] studied the effect of the aqueous
extract of A. paniculata on antioxidant defense system in lym-
phoma bearing AKR (an ecotropic N-tropic murine leukemia
virus) mice in liver. Oral administration of the aqueous extract
of plant in different doses caused a signiﬁcant elevation of
catalase, superoxide dismutase and glutathione-s-transferase
activities. Sheeja et al. [9] explored the antioxidant and anti-
inﬂammatory properties in methanolic extract of the plant
and found it to inhibit the formation of oxygen derived free
radicals such as superoxide (32%), hydroxyl radicals (80%),
lipid peroxidation (80%) and nitricoxide (42.8%) in vitro
system. In vivo studies using BALB/c mice models showed
signiﬁcant inhibition in phorbol-12-myristate-13-acetate
(PMA) induced superoxide (32.4%) and nitric oxide (65.3%)
formation. Tripathi and Kamat [11] examined aqueous extractfor antioxidant activity using rat liver subcellular organelles as
model systems and found that the extract shows potent
antiradical agent against various pathophysiological oxidants.
The isolated fractions effectively inhibited the toxic effect of
snake venoms in vitro than in vivo [12].
Andrographolide inhibited LPS (lipopolysaccharide)-in-
duced increase in tumor necrosis factor-alpha (TNF-a) and
granulocyte–macrophage colony stimulating factor [13].
Neoandrographolide also inhibits PGE2 (Prostaglandin E2)
synthesis and TNF-a in LPS-stimulated macrophages and its
oral administration to mice signiﬁcantly suppresses dimethyl
benzene-induced ear edema and acetic acid-induced vascular
permeability [14]. A reﬁned extract of A. paniculata, also
signiﬁcantly reduces activities of lipid peroxide, while the activ-
ities of nitric oxide, cyclic guanosine monophosphate (cGMP)
and superoxide dismutase are signiﬁcantly enhanced in
experimental atherosclerotic rabbits [15]. The aim of present
investigation is to highlight the anticarcinogenic, antimuta-
genic, and anticlastogenic potential of extracts of A. paniculata
in the in vitro and in vivo model.
2. Materials and methods
2.1. Materials
The whole plant was powdered into a mixture and the hydro-
alcoholic extract was prepared by reﬂuxing with the double
distilled water (DDH2O) and alcohol (3:1) in a round bottom
ﬂask for 48 h at 60 C. The liquid extract was ﬁltered, cooled
and concentrated by evaporating its liquid contents in oven
and collected. The powdered extract, termed Andrographia
extract (AE), was re-dissolved in DDH2O and the required
doses for treatment were prepared and ﬁve concentrations of
50, 75, 100, 150 and 200 mg/kg body weight were selected
for in vivo experiments and four concentrations of 50, 100,
200 and 250 mg/l of culture for in vitro experiments.
2.2. Aﬂatoxins B1
Aﬂatoxins are produced by Aspergillus ﬂavus and A. parasiti-
cus at any time during growth and post harvest storage of a
number of foodstuffs and the levels of contamination are en-
hanced under poor food harvesting and storage practices
[6,16] that lead to aﬂatoxin B1 exposure to human. The major
concern with respect to human health derives from the high
potency of aﬂatoxins to produce cancer in laboratory animals
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carcinogen in human populations [17–19].
2.3. In vivo study
Albino mice were cultured in animal house following Codes
and Commandments of Institutional Ethics Committee
regarding caring, handling and use of animals in the Research
and the work is carried out in accordance with the Code of
Ethics of the World Medical Association (Declaration of
Helsinki). Albino mice 8–10 weeks old were exposed to differ-
ent test chemicals by intra peritoneal injection and were sacri-
ﬁced at sequential intervals of 16, 24, and 32 h of stipulated
treatment time. Animals were treated with each test substance
as mentioned above. Further processes of slide preparations,
cells and chromosomal aberrations analyses are adopted from
earlier published work [4,5]. The reduction factors due to test
chemical treatments were calculated using the formula
published earlier [5,6].
2.4. In vitro lymphocytes culture method
The parameters studied included chromosomal aberrations
(CA), sister chromatid exchanges (SCEs) and cell growth
kinetics (RI) both in the presence and in the absence of exog-
enous metabolic activation system. The in vitro culture meth-
ods, preparation of S9 (microsomal fraction), media
preparation and analyses of chromosomal aberrations, sister
chromatid exchanges, cell cycle kinetics and statistical analysis
were followed as per the methodology published earlier [4–6].
3. Results
3.1. In vivo effects
In these in vivo experiments we have selected ﬁve most opti-
mum concentrations of aqueous extract of A. paniculata and
their effect on chromosomal aberrations given at three differ-
ent durations were calculated and presented in the tables.
As shown in Table 1 for 16 h of treatment duration, the
percentage of aberrant cells were 14.8% due to treatment with
Aﬂatoxin B1 (AFB1) which were reduced to 12.5%, 10.6%,Table 1 In vivo effects of Andrographia paniculata on the frequenc
(AFB1 x/kg.bw) at 16 h durations.
Treatment AE (Y/kg.bw) Cell with pulverized chromosome Types of
Gaps B
DDH2O 00 00 04 03
AFB1 00 12 35 53
AE5 AE5 00 05 02
AFB1 + AE AE1 08 27 45
AE2 05 20 38
AE3 03 22 32
AE4 01 16 26
AE5 00 05 21
Note: AE1-AE5; concentrations of Andrographia paniculata extracts, DD
weight at 16 h of treatment. Calculations were made excluding the gaps
* Signiﬁcant at <0.05 probability. Y/kg.bw is the concentration of extra8.9%, 7.7% and 6.8%, respectively for ﬁve consecutive con-
centrations of Andrographia extract. Similarly reduction in
the frequencies of clastogenic cells put the values at 15.54%,
28.37%, 39.86%, 47.97% and 54.05% against ﬁve different
concentrations of Andrographia extract, respectively. The trend
of effects was linear i.e., as concentration of Andrographia ex-
tract increases the effect also increases (Fig. 1). The gross effect
on the total number of frequencies per thousand cells was 231,
176, 137, 117 and 94 aberrations due to ﬁve increasing concen-
trations of Andrographia extract along with aﬂatoxin B1
against 311 aberrations of AFB1 alone. The normal values
were 21 for distilled water treatment (Table 2).
When the treatment duration was increased to 24 h, the
trends of effect were similar, with increasing values. The ob-
served values were 11.7%, 10.4%, 8.8%, 7.7% and 7.1% due
to ﬁve increasing concentrations of Andrographia extract,
against 14.0% of AFB1 alone. The normal values were 1.9%
and 2.2% for pure water and Andrographia extract alone,
respectively. It also shows the dose–response relationship
(Fig. 1). Effect of Andrographia extract on the frequency of
aberrations per cell and total aberrations noticed were much
signiﬁcant statistically. The total aberrations per thousand
cells were 196, 166, 134, 110 and 92 for Andrographia extract
against the value of 242 with AFB1 alone.
At 32 h of treatment, we observed the percentage of aber-
rant cells as 15.3% for AFB1 alone, and 12.2%, 9.9%,
8.7%, 7.7% and 6.8%, respectively for ﬁve different concen-
trations of Andrographia extract given with AFB1, whereas
the value for the normal control was 1.9%, and the same for
Andrographia extract alone was 1.8%. In terms of the effects
on the percent reduction in aberrant cells, the values were
20.26%, 35.29%, 43.13%, 49.67% and 55.56%, respectively.
These values were statistically signiﬁcant at <0.05 probability
level due to Andrographia extract on the number and percent-
age of aberrant cells. It also showed almost dose dependent
relationship, though the highest doses were much effective in
comparison with preceding dose. More of chromosomal ex-
change types of aberrations were seen in contrast to the previ-
ous two durations of treatment (Fig. 1). The total frequencies
per thousand cells were 324 for AFB1 only and 238, 157, 135,
114, and 87 aberrations, respectively for Andrographia extract
along with AFB1.y of cells with chromosome aberrations induced by aﬂatoxin B1
chromatic aberrations Aberrant cell no. (%) (%) Reduction
reaks Fragments Exchanges
18 00 21 (2.1)
80 04 148 (14.8)
16 00 18 (1.8)
70 02 125 (12.5) 15.54*
62 01 106 (10.6) 28.37
54 00 89 (8.9) 39.86*
50 00 77 (7.7) 47.97*
47 00 68 (6.8) 54.05*
H2O; Double Distilled water, AFB1; Aﬂatoxin B1 5 lg/ml /kg body
type of aberration.
cts of Andrographia paniculata.
Figure 1 In vivo anticarcinogenic effect of Andrographia paniculata extracts at 16, 24, and 31 h of treatment durations against AFB1
genotoxicity in Albino mice bone marrow cell.
Table 2 In vivo effects of Andrographia paniculata extract on the frequency of cells with chromosomal aberrations induced by
aﬂatoxin B1 (AFB1 x/kg.bw) at 16 h durations.
Treatment AE/kg.bw Cell with aberration Total number of aberration
0 1 2 3 4 5 6–9
DDH2O 00 979 17 04 00 00 00 00 25
AFB1 00 852 81 25 14 12 11 05 311
AE AE5 982 16 02 00 00 00 00 20
AFB1 + AE AE1 875 79 18 10 09 07 02 231
*
AE2 894 73 14 07 06 06 00 176
*
AE3 911 62 16 05 02 04 00 137
*
AE4 923 55 13 03 03 03 00 117
*
AE5 932 50 14 01 02 01 00 94
*
Note: AE1-AE5; concentrations of Andrographia paniculata extracts, DDH2O; Double Distilled water, AFB1; Aﬂatoxin B1 5 lg/ml /kg body
weight at 16 h of treatment. Calculations were made excluding the gaps type of aberration.
* Signiﬁcant at <0.05 probability. Y/kg.bw is the concentration of Andrographia paniculata extracts. The animals were sacriﬁced 16 h after
AFB1 treatment 1000 cells from 10 animals were analyzed for each point.
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Here the culture treated with Aﬂatoxin B1 (AFB1) resulted in
clastogenic abnormalities as observed in percent metaphase
aberrations, types of aberrations and aberrations per cell
(35.07%, 72.57% and 83.75% or 0.35, 0.73 and 0.84 aberra-
tions per cell) at single standard dose and three durations
viz., 24, 48 and 72 h, respectively whereas, with control, the
normal and DMSO plus Andrographia extract, these values
were (0.05, 0.05) per cell. Andrographia extract bring down
aberrations from 35.0% to 29.0%, 26.62%, 24.0% and
21.72% with four consecutive doses of the extract at 24 h of
duration, whereas at 48 h, it gets lowered from 62.0% to
55.92%, 49.0%, 47.00%, and 44.0% by administration of 1st
to 4th concentrations of Andrographia extract, respectively.
The same trends were noticed, when the treatment durationswere increased to 72 h. These values showed linear increasing
trends with doses, but it does not depend on durations. The
maximum percentage reductions in the aberrations were
37.94% for 24 h and 29.03% and 24.63%, respectively for
48 h and 72 h that were caused by highest doses of Androgra-
phia extract (Table 3 Fig. 2).
Similarly when the experiment was setup along with meta-
bolic activation system (+S9 mix) the effect of AFB1 got in-
creased. The effect of Andrographia extract also showed
similar trend; they lower the clastogenic activity of AFB1.
These values showed linearly increased with doses (Fig. 3).
The maximum effective percentage reductions were 42.60%,
26.08%, and 23.14% for 24, 48 and 72 h, respectively.
When sister chromatid exchanges were counted (Table 4,
Fig. 4) the reduction was evident both in the absence as well
as in the presence of metabolic activation; thereby lowering
Table 3 In vitro analysis of chromosomal aberration after treatment with aﬂatoxin B1 (AFB1) along with Andrographia paniculata
extract, in the absence of S9 mix.
Treatments Durations (h) Metaphase scored Percent aberration metaphase Types of aberration (%) Aberratio/cell ± SE
Including gap Excluding gap Chromatid Chromosome Total
AFB1
24 200 24.00 21.50 24.00 11.00 35.00 0.35 ± 0.04
48 200 38.00 34.00 42.00 20.00 62.00 0.62 ± 0.08
72 200 41.00 36.00 45.00 24.00 69.00 0.69 ± 0.09
AFB1 + AE1 24 200 22.98 20.50 22.00 7.00 29.00 0.29 ± 0.04
48 200 34.00 31.00 38.00 17.92 55.92 0.56 ± 0.06
72 200 39.00 34.57 42.00 22.67 64.67 0.65 ± 0.09
AFB1 + AE2 24 200 21.77 18.54 19.67 6.95 26.62 0.27 ± 0.03
48 200 32.00 29.00 34.00 15.00 49.00 0.49 ± 0.06
72 200 37.88 32.90 39.00 20.00 59.00 0.59 ± 0.08
AFB1 + AE3 24 200 19.00 16.00 18.00 6.00 24.00 0.24 ± 0.04
48 200 30.54 27.84 32.50 14.60 47.10 0.47 ± 0.05
72 200 34.00 30.00 37.00 18.62 55.62 0.56 ± 0.09
AFB1 + AE4 24 200 17.92 15.00 16.72 5.00 21.72 0.22 ± 0.03
48 200 29.85 26.00 31.00 13.00 44.00 0.44 ± 0.06
72 200 32.00 29.55 35.00 17.00 52.00 0.52 ± 0.06
Control
DDH2O 72 200 2.75 2.00 1.98 0.96 2.94 0.03 ± 0.01
AE2 72 200 3.85 1.56 2.88 1.00 3.88 0.04 ± 0.01
Note: AE1–AE4; concentrations of Andrographia paniculata extracts, DDH2O; Double Distilled water, AFB1; Aﬂatoxin B1 5 lg/ml/culture,
gaps type of aberration is not included, SE; Standard error, Calculations were signiﬁcant at <0.05 probability level.
Figure 2 Comparative in vitro anticlastogenic effect of Andrographia paniculata extracts in the absence of S9 mixture at 24, 48 and 72 h of
treatment duration.
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13.40 to 06.80 and in the presence of S9 from 14.60 to 07.50.
For the analysis of SCE, only 48 h of cultures were used and
50 metaphases were scanned.
The effects of Andrographia extract on replication index
(Table 5) showed an elevated level when compared with the
AFB1 treatment alone i.e., from 1.26 to 1.52, though still being
lower than the normal level of 1.76. The effect, after treatmentwith metabolic activation system, shows the level from 1.35 to
1.51, i.e., again being much effective in comparison to that
without metabolic activation system.
4. Discussion
Cancer results when cells do not respond to signals that are in-
tended to limit growth. If a cancer cell can be made to mature
Figure 3 In vitro anticlastogenic effect of Andrographia paniculata extracts in the presence of S9 mixture at 24, 48 and 72 h of treatment
duration.
Table 4 In vitro analysis of sister chromatid exchanges (SCE) after treatment with aﬂatoxin B1 along with Andrographia paniculata
extract, in the presence of S9 mix.
Treatment Duration (h) Metaphase scored Total Range SCE/cell ± SE
Aﬂatoxin B1 48 50 730 3–12 14.60 ± 1.00
AF B1 + AE1 48 50 580 3–12 11.60 ± 1.00
AF B1 + AE2 48 50 490 2–12 09.80 ± 0.70
AF B1 + AE3 48 50 410 1–11 08.20 ± 0.50
AF B1 AE4 48 50 375 1–11 07.50 ± 0.50
Control
DDH2O 48 50 240 0–6 04.80 ± 0.40
AE3 48 50 238 0–6 04.76 ± 0.40
Note: AE1–AE4; concentrations of Andrographia paniculata extracts, DDH2O; Double Distilled water, AFB1; Aﬂatoxin B1 5 lg/ml/culture,
SCE; sister chromatid exchange, SE; Standard error, Calculations were signiﬁcant at <0.05 probability level.
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control. A. paniculata was chosen because it contained sub-
stances (terpenes) that were known to cause differentiation
of cancer cells. The results of the previous study were demon-
strated that A. paniculata had potential cell differentiation-
inducing activity on leukemia cells [20].
The extracts have shown a broad-range anti-proliferative
activity on a variety of cancer cell lines including breast cancer,
colon cancer, hepatoma, cervical cancer, leukemia and pros-
tate cancer [21,22]. Among various breast cancer cell lines,
the MCF-7 cell lines were found to be most sensitive. As the
colorectal and colon cancer cells are observed to be more sen-
sitive toward andrographolide treatment.
A. paniculata possessed anticancer activity and the inhibi-
tion of the proliferation of colon cancer cells and augmenta-
tion of the proliferation of human peripheral blood
lymphocytes at low concentration were revealed by the
dichloromethane crude extract of the medicinal plant [23].
The anticancer activity was observed due to the presence ofandrographolide which demonstrated their direct anticancer
activity at G0/G1 phase of the cell cycle through induction
of cell cycle inhibitory protein p27. The expression of cyclin
dependent kinase 4 (CDK4) was decreased and the produc-
tion of tumor necrosis factor -a was increased that was con-
tributed to cytotoxicity of lymphocytes against cancer cells
[24]. The mechanism involved in the inhibition of tumor
growth was, to stimulate the cytotoxic T lymphocyte produc-
tion through increased secretion of interlukin-2 and inter-
feron–c [25]. Another study in the in vivo demonstrated
that the 70% ethanol extract of A. paniculata and andro-
graphlide increased the life spans of mice injected with thy-
moma cells [26].
Andrographolide induces apoptosis in human cancer cells
via the activation of caspase 8, pro-apoptotic Bcl-2 family
members Bax conformational change, release of cytochrome
C from mitochondria and activation of caspase cascade [27]
and also through the activation of tumor suppressor p53 by
ROS-dependent c-Jun NH2-terminal kinase (JNK) activation,
Figure 4 Antigenotoxic effect of Andrographia paniculata extracts on sister chromatid exchanges in the absence as well as in the presence
of metabolic activation system.
Table 5 In vitro analysis of cell cycle kinetics after treatment with aﬂatoxin B1 along with Andrographia paniculata extract, in the
presence of S9 mix.
Treatment Cell scored Percentage (%) cell in Replication index 2 · 3 Chi square test
M1 M2 M3
Aﬂatoxin B1 200 75 24 01 1.26
AFB1 + AE1 200 70 26 04 1.34
AFB1 + AE2 200 66 28 06 1.40 Signiﬁcant
AFB1 + AE3 200 62 31 07 1.45 Signiﬁcant
AFB1+ AE4 200 58 32 10 1.52 Signiﬁcant
Control
DDH2O 200 37 52 11 1.74
AE3 200 38 50 12 1.74
Note: 2 · 3 Chi square (v2) test was conducted, AE1–AE4; concentrations of Andrographia paniculata extracts, DDH2O; Double Distilled water,
AFB1; Aﬂatoxin B1 5 lg/ml/culture. Calculations were made at <0.05 probability level.
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stabilization [28,29]. Andrographolide may suppress an onco-
gene v-Src-induced transformation and down-regulate v-src
protein expression via the attenuation of ERK1/2 signaling
pathway [30].
Andrographolide inhibits the adhesion of cancer cells to the
activated endothelium by blocking E-selectin expression [31].
Andrographolide may also inhibit angiogenesis for tumor
metastasis via down-regulating matrix metalloproteinases-7
(MMP-7) expression, possibly by inactivating activator pro-
tein-1 (AP-1) through suppressing PI3K/Akt signaling path-
way [32,33]. Chao et al. [34] demonstrated that
andrographolide at nontoxic to subtoxic concentrations (0.3–
3 lM) suppressed the invasion ability of CT26 cells in Matri-
gel-based invasion assays.
Therapeutic efﬁcacy of a drug is reﬂected by its bioavail-
ability, when taken in the form of an extract, andrographolide
is readily absorbed in blood and maximum plasma concentra-
tions were reached after 1.5–2 h of oral administration [35]. It
is suggested that P-glycoprotein participates in the intestinalabsorption of andrographolide [36]. The available information
on the metabolism of the compound reﬂects that metabolic
fate of andrographolide in humans after oral administration
might involve a sulfonate reaction at C-12 [37].5. Conclusion
A. paniculata extracts signiﬁcantly reduced the number of
aberrant cells and frequencies of aberration per cell at each
concentration and duration of exposure in vivo; similarly it
reduced chromosomal aberrations and sister chromatid
exchanges and replication index was enhanced in vitro that
was statistically signiﬁcant at <0.05 level.
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